Кращі подкасти про Addiction Medicine (2026)

1
Navigating Choices: Pregnancy Options Counseling Experiences in Individuals With Opioid Use Disorder 15:09

4d ago15:09

15:09

In this episode, Dr. Blythe Bynum joins the show to discuss her new article titled Navigating Choices: Pregnancy Options Counseling Experiences in Individuals With Opioid Use Disorder, featured in the November/December issue of the Journal of Addiction Medicine. Dr. Blythe Bynum is an assistant professor in the Department of Obstetrics and Gynecolo…

1
Lead: Productivity Losses From Substance Use Disorder in the U.S. in 2023 7:42

27d ago7:42

7:42

Productivity Losses From Substance Use Disorder in the U.S. in 2023 American Journal of Preventive Medicine Information on morbidity-related productivity losses attributable to substance use disorder is limited. This study estimates morbidity-related productivity losses attributable to substance use disorder among U.S. adults aged ≥18 years in 2023…

1
70. Prescription Stimulant Misuse 47:05

28d ago47:05

47:05

In episode 70 we discuss anarticle about prescription stimulant misuse. Han B, Jones CM, Volkow ND, etal.PrescriptionStimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64Years.JAMA Psychiatry. 2025;82(6):572–581. We also discuss the ASAMtoolkit for addressing problems at the pharmacy with buprenorphine,and results of the 2024 NSDUH …

1
Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes 16:10

1M ago16:10

16:10

In this episode, Dr. Bradley Stein joins the show to discuss findings from his new study titled Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes, featured in the September/October issue of the Journal of Addiction Medicine. Dr. Bradley Stein is a practicing physician and senior physician policy researcher at RAND…

1
Lead: Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations 5:30

1M ago5:30

5:30

Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations Substance Use and Addiction Journal This is a narrative review of methadone and buprenorphine regulations, prescriber eligibility, dispensing models, and coverage across eight countries: the United States, Canada, the United Kingdom, Russia, France, Iran…

1
Lead: Very Low Nicotine Content Cigarettes for Smoking Cessation: Examining a Facilitated Extinction Approach and Dosing Schedule 5:06

1M ago5:06

5:06

Very Low Nicotine Content Cigarettes for Smoking Cessation: Examining a Facilitated Extinction Approach and Dosing Schedule Drug and Alcohol Dependence Very low nicotine cigarettes (VLNC, 0.4 mg nicotine/g tobacco) have been shown to reduce smoking behavior when compared to normal nicotine cigarettes (NNC,17 mg nicotine/g tobacco). Participants (n=…

1
69. Cytisinicline for Smoking Cessation 27:31

1M ago27:31

27:31

In episode 69 we discuss cytisinicline for smoking cessation. Rigotti NA, et al. Cytisinicline for Smoking Cessation: The ORCA Phase 3 Replication Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 1;185(6):648-655. We also discuss treating opioid use disorder in nursing homes and compulsive TikTok scrolling. Carolina Public Press: NC nursing hom…

1
Non-medical Mephentermine Use: A Systematic Review of Literature 46:47

2M ago46:47

46:47

In this episode, Dr. Vinit Patel sits down to discuss his new article Non-medical Mephentermine Use: A Systematic Review of Literature, as well as what exactly mephentermine is, why and how it is currently being used in non-medical settings specifically in India and South Asia, and some of the contributing factors associated with geographic dispari…

1
Lead: Fatal Opioid Overdoses by Historical and Contemporary Neighborhood-Level Structural Racism 7:58

2M ago7:58

7:58

Fatal Opioid Overdoses by Historical and Contemporary Neighborhood-Level Structural Racism🔓 JAMA Health Forum This cross-sectional study of 796 census tracts prior to the COVID-19 pandemic (2017-2019) and 792 census tracts during the COVID-19 pandemic (2020-2022) in Chicago, Illinois, assessed the extent to which there is a spatial association betw…

1
Lead: State Laws Banning Prior Authorization For Medications For Opioid Use Disorder Increased Substantially, 2015–23 7:37

2M ago7:37

7:37

State Laws Banning Prior Authorization For Medications For Opioid Use Disorder Increased Substantially, 2015–23 Health Affairs While medications for opioid use disorder (MOUD) is effective treatment, most patients with OUD don’t receive it and prior authorization (PA) has been a barrier to access. Researchers looked at state policies trying to addr…

1
68. Behavioral Treatments as an Adjunct to Buprenorphine 40:46

2M ago40:46

40:46

In episode 68 we discuss an article about adding behavioral treatments to buprenorphine for opioid use disorder. McHugh RK, et al. Behavioral Therapy as an Adjunct to Buprenorphine Treatment for Opioid Use Disorder: A Secondary Analysis of 4 Randomized Clinical Trials. JAMA Netw Open. 2025 Aug 1;8(8):e2528529. We also discuss online gambling addict…

1
S2 Ep23: #498 Opioid Withdrawal with Dr. Ashish Thakrar 1:13:21

2M ago1:13:21

1:13:21

Grow your management tools for opioid withdrawal in the hospital. Investigate how to decide between methadone and buprenorphine, additional medications to manage symptoms and how and when to use short-acting opioids for management of withdrawal. We’re joined by Ashish Thakrar, MD at the University of Pennsylvania. Claim CME for this episode at curb…

1
S2 Ep22: #497 Tailoring and Ramping up Management of Methamphetamine Use Disorder for the Current Era with Dr. Phillip Coffin 58:19

2M ago58:19

58:19

In this high-yield episode of Curbsiders Addiction Medicine, we dive deep into a practical and compassionate approach to caring for patients using methamphetamines and/or living with methamphetamine use disorder. We explore the latest pharmacologic options, harm reduction strategies, contingency management, and innovative ideas for monitoring and s…

1
Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals with an Addiction Consult Service 25:44

2M ago25:44

25:44

Dr. Jennifer McNeely stops by the show to discuss her new article Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals with an Addiction Consult Service. Article Link: Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals with an Addiction Consult Service…

1
Lead: Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine 7:08

2M ago7:08

7:08

Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine JAMA Network This industry-sponsored, multicenter, open-label randomized clinical trial with 729 participants, assessed if rapid induction (RI) for initiating extended-release buprenorphine is as safe and effective as standard induction (SI) in individuals who inject opioids o…

1
67. Rapid-Start Injectable Buprenorphine 26:18

2M ago26:18

26:18

In episode 67 we discuss an article about starting buprenorphine injectables without stopping fentanyl or going into opioid withdrawal. Waters RC, et al. Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting. JAMA Netw Open. 2025;8(8):e2527016. We also discuss over-the-counter magic mushrooms and banning cigarette f…

1
Lead: States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018–24 7:57

2M ago7:57

7:57

States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018–24 Health Affairs Multiple federal policy changes since 2018 intended to increase buprenorphine prescribing in response to a persistent treatment gap for opioid use disorder (OUD) in the US. Anticipated national increases did not occur, but hi…

1
66. Smoking in Recovery 31:49

2M ago31:49

31:49

In episode 66 we discuss an article about smoking during substance use disorder recovery. Parks MJ, Blanco C, Creamer MR, et al. Cigarette Smoking During Recovery From Substance Use Disorders. JAMA Psychiatry. Published online August 13, 2025. We also discuss how the White House is pressuring the FDA to fast-track nicotine products and shenanigans …

1
Lead: Ultra-processed food addiction in a nationally representative sample of older adults in the USA 7:20

3M ago7:20

7:20

Ultra-processed food addiction in a nationally representative sample of older adults in the USA Addiction Using a cross-sectional online and telephone survey of a nationally representative sample of older adults (aged 50–80 years) in the US, this study examined the prevalence of ultra-processed food addiction (UPFA) in older US adults and its assoc…

1
65. Varenicline and Bupropion for Alcohol Use Disorder 30:08

3M ago30:08

30:08

In episode 65 we discuss varenicline and bupropion for alcohol use disorder. Söderpalm B, Lidö H, Franck J, Håkansson A, Lindqvist D, Heilig M, Guterstam J, Samuelson M, Askerup B, Wallmark-Nilsson C, de Bejczy A. Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placeb…

1
Lead: Alcohol Consumption Per Capita and Suicide: A Meta-Analysis 5:08

3M ago5:08

5:08

Alcohol Consumption Per Capita and Suicide: A Meta-Analysis JAMA Network Open This meta-analysis that included 13 studies assessed if alcohol consumption per capita is associated with suicide mortality and, if so, does the association differ by sex. Researchers found that a 1-L increase in alcohol consumption per capita was associated with a 3.59% …

1
Lead: Measures of General Intelligence and Risk for Alcohol Use Disorder 7:14

3M ago7:14

7:14

Measures of General Intelligence and Risk for Alcohol Use Disorder JAMA Psychiatry This male Swedish cohort study that included 573,855 participants assessed if there is an association between IQ and risk for alcohol use disorder, and if so, what is the nature of this association. It found that IQ at age 18 years was associated with subsequent alco…

1
Lead: Medications for Opioid Use Disorder Playbook 7:12

3M ago7:12

7:12

Medications for Opioid Use Disorder Playbook Agency for Healthcare Research and Quality (AHRQ) The AHRQ Integration Academy developed the Medications for Opioid Use Disorder Playbook as a practical guide for providing medications for opioid use disorder (MOUD) and immediate care for patients with OUD in primary care and other ambulatory care settin…

1
Lead: Cannabis Use During Pregnancy and Lactation 7:06

3M ago7:06

7:06

Cannabis Use During Pregnancy and Lactation American College of Obstetricians & Gynecologists Cannabis is the most commonly used illicit drug under U.S. federal law. With increasing social acceptability, accessibility, and legalization in many states, the prevalence of cannabis use among pregnant and lactating individuals has increased significantl…

1
Lead: Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study 6:47

4M ago6:47

6:47

Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study American Journal of Psychiatry This national retrospective cohort study found that veterans with stimulant use disorder who received contingency management (CM) were 41% less likely to die in the year following treatment initiation relative to matched c…

1
S5 E6: Alcohol Use - When Is It A Problem And What Can Be Done? (Part 2) 45:22

4M ago45:22

45:22

Dr. David Ryan returns for Part 2 of his presentation from the North Carolina Academy of Family Physicians Alcohol Use Training Webinar. Building on the foundations from Part 1, this session takes a closer look at treatment options for alcohol use disorder. Dr. Ryan walks through FDA-approved medications, behavioral interventions, and the importanc…

1
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative 26:02

4M ago26:02

26:02

Dr. Pouya Azar stops by the show to talk about his recent article Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative. He discusses the potential benefits of transitioning patients with opioid use disorder from traditional to extended-release or long-acting buprenorphine w…

1
Lead: Machine learning– and multilayer molecular network–assisted screening hunts fentanyl compound 8:02

4M ago8:02

8:02

Machine learning– and multilayer molecular network–assisted screening hunts fentanyl compounds Science Advances Fentanyl and its analogs are a global concern, making their accurate identification essential for public health. This article introduces Fentanyl-Hunter, a screening platform that uses a machine learning classifier and multilayer molecula…

1
S5 E5: Alcohol Use - When Is It A Problem And What Can Be Done? (Part 1) 49:18

4M ago49:18

49:18

Dr. David Ryan shares Part 1 of his presentation from the North Carolina Academy of Family Physicians Alcohol Use Training Webinar. This session covers how to recognize when alcohol use becomes a concern, with an overview of screening tools, diagnostic criteria, and the neurobiology of addiction. Dr. Ryan also discusses current drinking guidelines,…

1
Lead: Evaluation of a Novel Patient-Centered Methadone Restart Protocol 7:25

4M ago7:25

7:25

Evaluation of a Novel Patient-Centered Methadone Restart Protocol 🔓 JAMA Network Open Restarting methadone for patients who have had a gap in treatment is often a frustratingly slow process for both the patient and provider. This cohort study of individuals examined outcomes for patients of a public, safety-net opioid treatment program before (n=78…

1
64. Screen Addiction and Suicide 38:09

4M ago38:09

38:09

In episode 64 we discuss an article about addictive screen use and suicide. Xiao Y, Meng Y, Brown TT, Keyes KM, Mann JJ. Addictive Screen Use Trajectories and Suicidal Behaviors, Suicidal Ideation, and Mental Health in US Youths. JAMA. 2025;334(3):219–228. We also discuss the impact of the first 100 days of the Trump administration on addiction tre…

1
Lead: Recommendations for Addressing In-Hospital Substance Use From a National Delphi Consensus Process 6:35

4M ago6:35

6:35

Recommendations for Addressing In-Hospital Substance Use From a National Delphi Consensus Process JAMA Network Open This survey study utilized a 3-round Delphi consensus process to identify best practices for addressing in-hospital substance use. A panel of 38 addiction experts developed 84 consensus-based and patient-centered recommendations which…

1
Relationship Between Methadone Induction Dosing and Retention in Treatment in Opioid Treatment Programs 17:02

5M ago17:02

17:02

Host Dr. Shawn McNeil is joined by Dr. Robert Sherrick to discuss his new article Relationship Between Methadone Induction Dosing and Retention in Treatment in Opioid Treatment Programs featured in the July/August issue of the Journal of Addiction Medicine. Robert Sherrick, MD, DFASAM, is chief science officer for Community Medical Services, a comp…

1
Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting 7:00

5M ago7:00

7:00

Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting JAMA Network Open Injectable-only buprenorphine protocols are an exciting new strategy for buprenorphine initiation, particularly in the fentanyl era. This is a cohort study of 95 patients with moderate to severe opioid use disorder who received care in a low-thr…

1
51-60 Round-Up 58:26

5M ago58:26

58:26

Quick summaries of articles 51-60. Enjoy! 51. Fun Activities and Recovery Acuff, S. F., et al. A brief measure of non-drug reinforcement: Association with treatment outcomes during initial substance use recovery. Drug and Alcohol Dependence, 256, 111092. 52. Buprenorphine-precipitated Fentanyl Withdrawal Thakrar AP, et al. Buprenorphine-Precipitate…

1
S5 E4: Expanding MOUD Access: Prescriber–Pharmacy Collaboration in Practice 23:39

5M ago23:39

23:39

In this episode, host Cheryl Viracola, Director of Practice Advancement with the North Carolina Association of Pharmacists, speaks with Dr. Vera Reinstein and Dr. Charles McCormick about how prescribers and pharmacists can work together to expand access to medication for opioid use disorder (MOUD). They explore how collaborative care models make tr…

1
Lead: Association between housing status and mental health and substance use severity among individuals with opioid use disorder and co-occurring depression and/or PTSD 5:51

5M ago5:51

5:51

Association between housing status and mental health and substance use severity among individuals with opioid use disorder and co-occurring depression and/or PTSD BMC Primary Care This is a cross-sectional analysis of associations between housing status and mental health and substance use severity among primary care patients with co-occurring disor…

1
Lead: Oral methadone versus sublingual buprenorphine for the treatment of acute opioid withdrawal: A triple-blind, double-dummy, randomized control trial 5:16

5M ago5:16

5:16

Oral methadone versus sublingual buprenorphine for the treatment of acute opioid withdrawal: A triple-blind, double-dummy, randomized control trial Drug and Alcohol Dependence Researchers compared oral methadone to sublingual buprenorphine for the management of acute opioid withdrawal. Patients at an inpatient drug treatment center in India were ra…

1
Keeping up with the Addiction Medicine Literature 47:15

5M ago47:15

47:15

Four addiction specialists talk about what it takes to keep yourknowledge current. The Addiction Medicine Journal Club is joined byDr. Casey Grover (AddictionMedicine Made Easy Podcast) andThomas Bannard (VCU Health) to discuss how to furtheryour knowledge as a busy professional. PSAM Review (Page 6):Staying Current: How to Keep up with the Addicti…

1
S5 E3: Inside NCSAM - What They Do and Why It Matters 16:23

5M ago16:23

16:23

In this episode, host Pollen Williamson, Director of Physician and Advanced Practice Provider Initiatives at the Governor’s Institute, sits down with Dr. Michael Baca-Atlas—family physician, addiction medicine specialist, and current President of the North Carolina Society of Addiction Medicine (NCSAM). Together, they explore the vital role of NCSA…

1
Lead: Implementation Gaps in US Syringe Service Programs, 2022 5:54

5M ago5:54

5:54

Implementation Gaps in US Syringe Service Programs, 2022 JAMA This study performed a cross-sectional analysis of the Syringe Services Programs in the US (SSPUS) dataset to determine implementation gaps. 613 syringe service programs (SSPs) included in the dataset were geocoded to county boundaries, which were then analyzed for urbanicity and SSP nee…

1
Lead: Co-involvement of stimulants with opioids in North America: A 'silent epidemic’ 7:19

6M ago7:19

7:19

Co-involvement of stimulants with opioids in North America: A 'silent epidemic’ Plos Mental Health The opioid epidemic unfolded in three distinct waves, with the latest being deaths attributed to illegally manufactured synthetic opioids. Using U.S. and Canadian data, this study reviews evidence for a 'silent epidemic' alongside the opioid epidemic …

1
63. Buprenorphine Dose and Neonatal Opioid Withdrawal 36:06

6M ago36:06

36:06

In episode 63 we discuss the association between buprenorphine dose and neonatal opioid withdrawal syndrome. Marc B, Marion D, François B, Lakshmipriya L. Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity? Am J Addict. 2025 Jan;34(1):15-20. We also discuss private equity in health care and nitrous oxide (Ga…

1
S5 E2: Motivational Interviewing for Adolescents: Components, Uses, and Training Resources 54:47

6M ago54:47

54:47

In this episode, Peter Rives, MSW, LCSWA, LCASA, shares his presentation from the Governor’s Institute’s 2025 Adolescent Substance Use Disorder Conference. Focused on motivational interviewing (MI), this session explores how MI can be used to effectively engage adolescents in conversations about behavior change—especially when they're feeling unsur…

1
Lead: Did alcohol facilitate the evolution of complex societies? 6:52

6M ago6:52

6:52

Did alcohol facilitate the evolution of complex societies? Humanities and Social Sciences Communications This study tested the “drunk” hypothesis, which claims that alcohol promoted social bonding and cooperation, aiding the rise of complex societies. Using data from 186 non-industrial societies, they found a modest positive link between indigenous…

1
Lead: Disparities in Treatment and Referral After an Opioid Overdose Among Emergency Department Patients 7:17

6M ago7:17

7:17

Disparities in Treatment and Referral After an Opioid Overdose Among Emergency Department Patients JAMA Network Open This cohort study of 1,683 patients assessed if there are racial and ethnic disparities in treatment referral rates among patients in the emergency department (ED) with opioid overdose. It found a statistically significant difference…

1
62. Naltrexone Pills vs Injections for Alcohol Use Disorder 36:14

6M ago36:14

36:14

In episode 62 we discuss the article “Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients with Alcohol Use Disorder.” Magane KM, et al. Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 1;185(6):635-645. We also discuss redu…

1
Nonabstinence Among US Adults in Recovery From an Alcohol or Other Drug Problem 19:32

6M ago19:32

19:32

Dr. Emily Pasman stops by the show to talk about her recent article Nonabstinence Among US Adults in Recovery From an Alcohol or Other Drug Problem. She discusses the findings from her study as well as the potential limitations of using a solely abstinence-focused treatment and recovery model for addiction care. Emily Pasman is a licensed social wo…

1
Lead: Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing 5:23

6M ago5:23

5:23

Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing Journal of General Internal Medicine This study used interrupted-time-series analysis to model prescriber-level trends in buprenorphine prescriptions after recent federal policy changes. It found that the eliminati…

1
S5 E1: Opioid Treatment Programs In North Carolina 19:19

6M ago19:19

19:19

In this episode of the Addiction Medicine Podcast, we’re joined by Anna Stanley, State Administrator of the State Opioid Treatment Authority (SOTA), to discuss the role of Opioid Treatment Programs (OTPs) in addressing the opioid crisis in North Carolina. We explore what OTPs are, common barriers to access like stigma and transportation, recent pol…

Подкасти, які варто послухати

Подкасти на тему Addiction Medicine

Подкасти, які варто послухати

Короткий довідник